scholarly journals Hypofractionated Whole Breast Irradiation in Large-Breasted Women – Is There A Predictor for Acute Skin Toxicity?

Author(s):  
A.K. Patel ◽  
D.C. Ling ◽  
A. Richman ◽  
C.E. Champ ◽  
M.S. Huq ◽  
...  
2014 ◽  
Vol 25 ◽  
pp. iv98
Author(s):  
L. Veldeman ◽  
S. De Langhe ◽  
V. Remouchamps ◽  
A. van Greveling ◽  
M. Gilsoul ◽  
...  

2021 ◽  
Author(s):  
Peiling Dai ◽  
Kai Chen ◽  
Lan Li ◽  
Li Wang ◽  
Yaoxiong Xia ◽  
...  

Abstract PurposePostoperative radiotherapy can reduce the recurrence of breast cancer. Postoperative radiotherapy is divided into whole breast irradiation (WBI) and partial breast irradiation (PBI) for early breast cancers. Due to the characters of saving time, money, and easy to deliver, external beams PBI (EB PBI) is brought into focus. However, the researches on outcomes, safety, and efficacy between EB PBI and WBI are still insufficient. We concluded a meta-analysis for LRR, regional node recurrence, contralateral breast cancer, distant recurrence, mortality, less acute skin toxicity (˃ 1 grade), late skin toxicity and the cosmetic score of external beam partial breast irradiation (EB PBI) and whole breast irradiation(WBI) to develop a radiotherapy plan for early low recurrence risk breast cancer patients. MethodWe searched Pubmed、Embase、Cochrane Library、Clinicaltrals. Study eligibility criteria are as below: (1) RCTs for EB PBI vs WBI; (2) Histologically confirmed breast cancer; (3) AJCC staged Tis-2N0-1M0; (4) ≥ 40 years old; (5) Tumor size ≤ 3 cm;(6) microscopically clear margins ≤ 5 cm; (7) Mean follow-up time༞5 years. All data is used by Cochrane’s Review Manager 5.3 (RevMan) to process.ResultsThere were 4 RCT studies included in our study with 1999 patients in EB PBI group and 1999 patients in EB PBI. There was no statistic difference between PBI and WBI groups in local recurrence rates (RR = 1.15; 95% CI, 0.76 to 1.74; p = 0.52; I2 = 0%), regional node recurrence(RR = 1.00; 95% CI, 0.49 to 2.04, p = 0.99, I2 = 0%), contralateral breast cancer (RR = 0.79; 95% CI, 0.54 to 1.16; p = 0.23; I2 = 0%), distant recurrence(RR = 1.00; 95% CI, 0.63 to 1.59; p = 1.00; I2 = 0%), non-breast second cancer (RR = 1.03; 95% CI, 0.50 to 2.16; p = 0.93; I2 = 83%), mortality(RR = 0.96; 95% CI, 0.60 to 1.55; p = 0.88, I2 = 54%). EB PBI had worse cosmetic score (RR = 1.56; 95% CI, 1.04 to 2.34; p = 0.003, I2 = 84%), less acute skin toxicity (˃ 1 grade) (RR = 0.17; 95% CI, 0.07 to 0.42; p༜ 0.0001, I2 = 87%) and late skin toxicity(RR = 0.65; 95% CI, 0.48 to 0.88; p = 0.005; I2 = 27%) than WBI.ConclusionEB PBI has similar LRR, regional node recurrence, contralateral breast cancer, distant recurrence, non-breast second cancer and mortality with WBI. But EB PBI has worse cosmetic score, less acute skin toxicity (˃ 1 grade) and late skin toxicity than WBI.


2020 ◽  
Vol 152 ◽  
pp. S336-S337
Author(s):  
S. Guihard ◽  
C. Petit ◽  
J.B. Clavier ◽  
L. Jung ◽  
S. Servagi Vernat ◽  
...  

2020 ◽  
Vol 20 (6) ◽  
pp. 527-533
Author(s):  
Fiorenza De Rose ◽  
Antonella Fogliata ◽  
Davide Franceschini ◽  
Cristina Iftode ◽  
Giuseppe R. D’Agostino ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document